According to the MHRA/EMC SmPC for Ozempic, nausea is very common (affecting 1/10 patients)

"These findings support a potential new therapeutic tool to effectively improve HbA1c levels well below 7% in such a challenging population of inadequately controlled basal insulin-treated type 2 diabetes with the benefit of substantial weight loss, no increase of hypoglycemia risk, and without having to increase insulin doses," said Julio Rosenstock, MD, lead author of the REIMAGINE 3 study. "As we look to provide more solid options for people with type 2 diabetes beyond insulin-based therapies, it's also important to note the safety and tolerability profile was consistent with previous GLP-1 RA trials." "Rather than focusing on glucose control alone, this strategy addresses weight, cardiovascular risk, and metabolic health together, with the goal of preventing long-term complications and, for some people, fundamentally resetting the trajectory of diabetes itself," said Vanita Aroda, MD, lead author of REIMAGINE 1. References American Diabetes Association

Loss of Lean Mass Weight loss includes both fat and lean tissue
The $298 Precision Peptide Genetic Test analyzes key variants like MC4R rs17782313 across 14 metabolic pathways
Shah, Zameer Ahmed, Hina Abbas, Geetha K